# Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain

> **NCT06723821** · NA · COMPLETED · sponsor: **University of Alcala** · enrollment: 40 (actual)

## Conditions studied

- COVID-19
- Musculoskeletal Pain

## Interventions

- **OTHER:** Neuromodulation group
- **OTHER:** Neuromodulation sham group

## Key facts

- **NCT ID:** NCT06723821
- **Lead sponsor:** University of Alcala
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-15
- **Primary completion:** 2025-10-15
- **Final completion:** 2026-04-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06723821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06723821, "Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06723821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*